Terms Defined Elsewhere Clause Samples
POPULAR SAMPLE Copied 1 times
Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: “Acquisition Proposal” Section 8.4 “Agreement” Preamble “AIP” Section 5.8(g) “Assumed RSU” Section 2.4(b)
Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: Agreement Preamble Board Observer 5.3(b) Company Preamble Confidential Information 5.2(a) Corporate Opportunity Party 5.7 Demand 4.1(a) Demand Registration 4.1(a) Drag Notice 3.7(b) Drag-Along Sale 3.7(a) Dragged Shareholders 3.7(a) Dragging Shareholders 3.7(a) Excess Shares 2.1(c) Executive Transfer 3.2(c) Family Member 3.2(b) Form S-3 Registration Statement 4.3(b) Form S-3 Shelf Registration Statement 4.3(b) Fully Participating Shareholder 2.1(c) Initial Exercise Period 3.5(b) Initial Purchaser 2.1(g) Initiating Shelf Holder 4.4(a) IPO Holdback Period Appendix Legend 6.1 Marketed Underwritten Shelf Take-Down 4.4(b) New Issuance 2.1(a) New Issuance Notice 2.1(a) Non-Electing Shares 3.6(d) Non-Marketed Underwritten Shelf Take-Down 4.4(c) Non-Marketed Underwritten Shelf Take-Down Notice 4.4(d) Notice Recipient 4.4(d) Offer Notice 3.5(a) Offer Price 3.5(a) Offered Securities 2.1(a) Offered Tag-Along Sale Shares 3.6(b)
Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: “2004 Incentive Plan” Section 6.10(f) “Affiliate Agreement” Recitals “Agreement” Preamble “Antitrust Filing” Section 6.5(b) “Balance Sheet” Section 3.10(c) “Benefits Date” Section 6.10(b) “Certificate” Section 2.1(a)(i) “Certificate of Merger” Section 1.2 “Change of Recommendation” Section 6.4(e) “Closing” Section 1.2 “Closing Date” Section 1.2 “Code” Recitals “Company” Preamble “Company Benefit Plan” Section 3.10 “Company Bylaws” Section 3.3 “Company Certificate” Section 3.3 “Company Common Stock” Section 2.1(a)(i) “Company Disclosure Letter” Article 3 “Company Financial Advisor” Section 3.23 “Company Form 10-K” Section 3.3 “Company Material Contract” Section 3.13 “Company Pension Plans” Section 3.10(a) “Company Permits” Section 3.7 “Company Preferred Stock” Section 3.4(a) “Company Recommendation” Section 6.1(c) “Company Rights Agreement” Section 2.1(c)(ii) “Company SEC Filings” Section 3.8(a) “Company Stockholder Approval” Section 3.24 “Company Stockholders’ Meeting” Section 6.2 “Company Subsidiaries” Section 3.1 “Company Welfare Plans” Section 3.10(a) “Confidentiality Agreement” Section 6.3(b) “Continuation Period” Section 6.10(b) “DGCL” Recitals “Effective Time” Section 1.2 “Employment Agreements” Recitals “ERISA Affiliate” Section 3.10(a) “ESPP” Section 2.5 “Exchange Agent” Section 2.2(a) “Exchange Fund” Section 2.2(a) “FDA” Section 3.7 “FDCA” Section 3.7 “Former Superior Proposal” Section 6.4(d) “HMO” Section 3.10(i) “LLC Act” Recitals “Merger” Recitals “Merger Consideration” Section 2.1(a)(i) “Merger Sub” Preamble “Offering Memorandum” Section 3.30 “Outside Date” Section 8.1(b) “Owned Real Properties” Section 3.20(b) “Parent” Preamble “Parent Bylaws” Section 4.2 “Parent Certificate” Section 4.2 “Parent Plans” Section 6.10(c) “Parent Rights Agreement” Section 2.1(c)(i) “Parent SEC Filings” Section 4.6(a) “Parent Subsidiary” Section 4.9 “Proxy Statement” Section 6.1(a) “Registration Statement” Section 6.1(a) “Regulatory Conditions” Section 8.1(b) “Representatives” Section 6.3(a) “▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act” Section 3.26 “Section 16” Section 6.19 “Stock Purchase Agreement” Section 6.15 “Superior Proposal Notice” Section 6.4(c) “Surviving Entity” Section 1.1 “Termination Fee” Section 8.2(e)(i) “Transition Assistance Plans” Section 2.4 “UK Stock Option Plans” Section 2.4 “VEBAs” Section 3.10(a) “Voting Agreements” Recitals
Terms Defined Elsewhere. As used in this Agreement, the following capitalized terms are defined in this Agreement as referenced in the following table: Agreement Preamble Applicable Date 4.5(a) Book-Entry Shares 3.3(b)(ii) Certificate of Merger 2.2(b) Certificates 3.3(b)(i) Change of Control Amendment 6.23(c)(ii) Change of Control Amendment Consent Fee 6.23(c)(ii) Closing 2.2(a) Closing Date 2.2(a) Code Recitals Company Preamble Company 401(k) Plan 6.9(f) Company Affiliate 9.10 Company Alternative Acquisition Agreement 6.3(d)(iv) Company Board Recitals Company Board Recommendation 4.3(a) Company Capital Stock 4.2(a) Company Change of Recommendation 6.3(d)(vii) Company Common Stock Recitals Company Contracts 4.19(b) Company Designees 2.7(a) Company Designated Stockholder Recitals Company Disclosure Letter Article IV Company Employee 6.9(b) Company FA 4.22 Company Independent Petroleum Engineers 4.17(a) Company Intellectual Property 4.14(a) Company Material Adverse Effect 4.1 Company Material Leased Real Property 4.15 Company Material Real Property Lease 4.15 Company Owned Real Property 4.15 Company Permits 4.9(a) Company Preferred Stock 4.2(a) Company Related Party Transaction 4.24 Company Reserve Report 4.17(a) Company Restructuring Transactions Recitals Company SEC Documents 4.5(a) Company Senior Notes Recitals Company Stakeholders’ Pro Forma Equity Percentage 5.22 Company Stock Award 3.2(a) Company Stockholders Meeting 4.4 Company Tax Certificate 6.18(b) Confidentiality Agreement 6.7(b) Creditors’ Rights 4.3(a) days 9.4(e) Designated Stockholder Support Agreement Recitals DGCL 2.1 Dismissal Order 6.24(a)(v) D&O Insurance 6.10(d) DTC 3.3(b)(ii) e-mail 9.3 Effective Time 2.2(b) Eligible Shares 3.1(b)(i) Exchange Agent 3.3(a) Exchange Consideration 6.23(a) Exchange Fund 3.3(a) Exchange Offer Recitals Exchange Offer Expiration Date 6.23(c) Exchange Prospectus 4.8 Exchange Ratio 3.1(b)(i) Exchange Registration Statement 4.8 Excluded Employees 6.9(b) Excluded Shares 3.1(b)(iii) GAAP 4.5(b) HSR Act 4.4 Indemnified Liabilities 6.10(a) Indemnified Persons 6.10(a) Involuntary Insolvency Event Date 6.24(a)(v) Joint Proxy Statement 4.4 Letter of Transmittal 3.3(b)(i) made available 9.4(e) Material Company Insurance Policies 4.20 Material Parent Insurance Policies 5.20 Measurement Date 4.2(a) Merger Recitals Merger Consideration 3.1(b)(i) Merger Registration Statement 4.8 Merger Sub Preamble Merger Sub Board Recitals Minimum Participation Condition 6.23(a) New Financing 6.22 Non-Cancelled Sh...
Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below:
Terms Defined Elsewhere. The following is a list of additional terms used in this Agreement and a reference to the Section hereof in which such term is defined: Agreement Preamble Biogen Idec License Agreement Section 4.7 Biogen Idec Supply Agreement Section 4.7 Books and Records Section 2.12(f)(2) Claim Notice Section 8.3(a) Closing Section 2.3 Closing Date Section 2.3 Company Preamble Company Common Stock Section 2.8 Company Disclosure Schedule Article IV Company Expenses Schedule Section 2.13 Company Indemnified Parties Section 8.2(a)(ii) Contracts Section 4.8(a) Covered Party (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c) Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Parties Section 8.2(a)(i) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g)
Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: 401(k) Termination Date Section 7.7(c) Acceptance Time Section 1.1(f) Adjusted Option Section 3.4(b) Adjusted RSU Section 3.4(d) Agreement Preamble Arrangements Section 7.14 Book-Entry Shares Section 3.2(b) Cancelled Shares Section 3.1(b) Certificates Section 3.2(b) Change of Recommendation Section 6.3(a) Closing Section 2.2 Closing Date Section 2.2 COBRA Section 4.10(d) Company Preamble Company Benefit Plans Section 4.10(a) Company Board of Directors Recitals Company Board Recommendation Recitals Company Capitalization Date Section 4.2(a) Company Common Stock Recitals Company Compensation Committee Section 7.14 Company Disclosure Letter Article IV Company Equity Schedule Section 4.2(b) Company Permits Section 4.9(b) Company Preferred Stock Section 4.2(a) Company SEC Documents Section 4.5(a) Company Shares Recitals Company Stockholders Recitals Convertible Senior Notes Section 7.15 DGCL Recitals Dissenting Shares Section 3.3(a) DOJ Section 7.2(b) Enforceability Limitations Section 4.3(c) Exchange Agent Section 3.2(a) Exchange Fund Section 3.2(a) Fractional Share Consideration Section 3.1(a) FTC Section 7.2(b) GAAP Section 4.5(b) Indemnified Parties Section 7.4(a) Indenture Section 7.15 Intervening Event Section 6.3(d) Material Contract Section 4.17(a) Minimum Condition Section 1.1(a)(i)
Terms Defined Elsewhere. For purposes of this Agreement, the following terms (as capitalized below) will have the following meanings when used in this Agreement: Action Section 5.10(b) Agreement Preamble Appraisal Rights Section 2.1(b) Board of Directors Recitals Book-Entry Shares Section 2.2(a) Cancelled Shares Section 2.1(a)(ii) Certificate of Merger Section 1.3 Certificates Section 2.2(a) Change of Recommendation Section 5.4(e) Closing Section 1.2 Closing Date Section 1.2 Code Section 2.2(b)(iii) Common Stock Section 2.1(a)(i) Company Preamble Company Disclosure Letter Article 3 Company Employees Section 5.6(a) Company Post-Signing RSU Award Section 2.3(c) Company Related Parties Section 7.3(a) Company SEC Reports Section 3.5(a) Company Stockholders’ Meeting Section 5.5(b) Company Termination Fee Section 7.3(a) Confidentiality Agreement Section 5.3(b) Development Real Property Section 3.9(e) DFARS Section 3.20(c) DGCL Recitals Dissenting Shares Section 2.1(b) EAR Section 3.15(d) E▇▇▇▇ Article 3 Effective Time Section 1.3 End Date Section 7.1(b) ESPP Section 3.2(b)(i) Exchange Fund Section 2.2(a) Filed SEC Reports Article 3 Financing Amounts Section 4.12 HSR Act Section 3.4 Indemnified Party Section 5.10(b) Intervening Event Notice Section 5.4(f) Leases Section 3.9(a) Legal Restraint Section 6.1(b) Major Customer Section 3.13(a) Major Supplier Section 3.13(b) Material Contract Section 3.11(a) Maximum Amount Section 5.10(c) Measurement Time Section 3.2(a) Merger Recitals Merger Consideration Section 2.1(a)(i) Merger Sub Preamble New Plans Section 5.6(b) Old Plans Section 5.6(b) Owned Real Property Section 3.9(a) Parent Preamble Parent Approvals Section 4.2(b) Parent Disclosure Letter Article 4 Parent Material Adverse Effect Section 4.1 Parent Related Parties Section 7.3(a) Parent RSU Award Section 2.3(c)(i) Paying Agent Section 2.2(a) Proposed Dissenting Shares Section 2.1(b) Recommendation Section 3.3 Remedial Action Section 5.7(b) Representatives Section 5.3(a) Required Company Stockholder Vote Section 3.23 Sexual Misconduct Allegation Section 3.18(c) Share Section 2.1(a)(i) Specified Approvals Section 3.4 Standards Organization Section 3.10(b) Superior Proposal Notice Section 5.4(e) Surviving Corporation Section 1.1 Takeover Statute Section 3.22 Termination Date Section 5.1(a) WARN Act Section 3.18(a)
Terms Defined Elsewhere. The following terms are defined herein in the sections identified below:
Terms Defined Elsewhere. The following terms are defined in this Agreement as follows: “Agreement” Preamble